2019

06 Founded ImmunoBiome, Inc.

07 Seed Financing

10 Obtained certification of a Venture company

12 Pre-A Series Financing Technology transfers from

IBS and POSTECH

2020

02 Established the corporate affiliated research center

08 Moved the headquarters to Bio Open
Innovation Center

09 Series-A Financing

10 Signed CDMO contract with Biose

Industrie, a French company

05 Conducted pre-clinical study for IMB002

06 Completed pre-clinical study for IMB001

09 MOU for co-development with Hy

(former Korea Yogurt)

08 IMB002 Preclinical trial completion

10 IMB002 cGMP production completion

03 Addition of Health Functional Food Business Sector

05 Patent Registration in Japan for
Microbiome-Derived Polysaccharides

08 Approval of IMB002 IND

04 Joint Research Agreement Signed with hy

04 Publication of Paper in Nature Immunology

05 Initiation of IMB002 Clinical Trials

07 Health Functional Food product launch